Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No intraday reading yet this session.
Xenon Pharmaceuticals Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
XENE (Xenon Pharmaceuticals Inc.) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BHC +10.05%, in healthcare.
316 institutional managers report a position in Xenon Pharmaceuticals Inc. worth $6.2B between them, filed on form 13F for the quarter ending 2026-06-30. 44 of them hold 80% of it, the largest being FMR LLC at 9.45%.
291 more managers in the register
44 managers hold 80% of the $6.2B institutional base. The other 272 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via venBio Select Advisor LLC, Driehaus Capital Management LLC, Jupiter Topco LLC +12 more · 5.66% of XENE, 6.01% of DFTX
via venBio Select Advisor LLC, Jupiter Topco LLC, Capital International Investors +9 more · 5.66% of XENE, 7.55% of ASND
via venBio Select Advisor LLC, Jupiter Topco LLC, Driehaus Capital Management LLC +11 more · 5.66% of XENE, 9.62% of GPCR
via Driehaus Capital Management LLC, Jupiter Topco LLC, Polar Capital Holdings Plc +12 more · 4.33% of XENE, 5.22% of CRNX
via venBio Select Advisor LLC, Jupiter Topco LLC, Wellington Management Group LLP +11 more · 5.66% of XENE, 7.63% of MDGL
via Jupiter Topco LLC, Driehaus Capital Management LLC, Deerfield Management Co +15 more · 4.10% of XENE, 9.85% of PRAX
Managers holding a meaningful stake in XENE also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.